-+ 0.00%
-+ 0.00%
-+ 0.00%

*Insight Molecular Diagn: Submitted GraftAssureDx for Kidney Transplant Rejection Testing for FDA Review on March 25 >IMDX

Dow Jones·03/26/2026 20:16:00

Please log in to view news